Orange Book product · Brand (NDA)
VANCOMYCIN HYDROCHLORIDE
VANCOMYCIN HYDROCHLORIDE
At a glance
Aug 01, 2025
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Aug 01, 2025
11 mo ago
Today
Pharmaceutical detail
Active ingredient
VANCOMYCIN HYDROCHLORIDE
Strength
EQ 1.5MG BASE/VIAL
Dosage form
POWDER
Route
INTRAVENOUS, ORAL
TE code
Not listed
Application
NDA 210274
Product number
007
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2018FIRVANQ KITBrand (NDA)
NDA 208910 · AZURITY
- 1986VANCOCIN HYDROCHLORIDEBrand (NDA)
NDA 050606 · ANI PHARMS
- 2023VANCOMYCIN HYDROCHLORIDEGeneric (ANDA)
ANDA 215338 · AMNEAL
- 2022VANCOMYCIN HYDROCHLORIDEGeneric (ANDA)
ANDA 214913 · ALKEM LABS LTD
- 2022VANCOMYCIN HYDROCHLORIDEGeneric (ANDA)
ANDA 215195 · MEITHEAL
- 2022VANCOMYCIN HYDROCHLORIDEGeneric (ANDA)
ANDA 215197 · MEITHEAL
- 2022VANCOMYCIN HYDROCHLORIDEGeneric (ANDA)
ANDA 215196 · MEITHEAL
- 2022VANCOMYCIN HYDROCHLORIDEGeneric (ANDA)
ANDA 216591 · ASPIRO
- 2022VANCOMYCIN HYDROCHLORIDEGeneric (ANDA)
ANDA 213059 · KNACK
- 2021VANCOMYCIN HYDROCHLORIDEGeneric (ANDA)
ANDA 215821 · SLATE RUN PHARMA
- 2020VANCOMYCIN HYDROCHLORIDEGeneric (ANDA)
ANDA 203300 · HIKMA
- 2019VANCOMYCIN HYDROCHLORIDEGeneric (ANDA)
ANDA 212332 · SLATE RUN PHARMA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

